![1,1-Dimethylethyl 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F35387-11-dimethylethyl-2-2s-3s-3-11-dimethylethoxy-carbonyl-amino-2-hydroxy-4-phenylbutyl-2-4-2-pyridinyl-phenyl-methyl-hydrazinecarboxylate.webp&w=3840&q=75)
CAS 198904-86-8
:1,1-Dimethylethyl 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylate
Description:
1,1-Dimethylethyl 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylate, with CAS number 198904-86-8, is a complex organic compound characterized by its intricate molecular structure. It features multiple functional groups, including hydrazine, carboxylate, and amine functionalities, which contribute to its potential biological activity. The presence of a dimethylethyl group suggests a degree of steric hindrance, which may influence its reactivity and interactions with biological targets. The compound also contains a phenyl group and a pyridine moiety, indicating potential aromatic characteristics that could affect its solubility and stability. Its stereochemistry, particularly the (2S,3S) configuration, is crucial for its biological activity, as stereoisomers can exhibit significantly different properties. Overall, this compound may be of interest in medicinal chemistry and drug development, particularly in the context of its potential therapeutic applications. However, detailed studies would be necessary to fully elucidate its properties and biological effects.
Formula:C32H42N4O5
InChI:InChI=1S/C32H42N4O5/c1-31(2,3)40-29(38)34-27(20-23-12-8-7-9-13-23)28(37)22-36(35-30(39)41-32(4,5)6)21-24-15-17-25(18-16-24)26-14-10-11-19-33-26/h7-19,27-28,37H,20-22H2,1-6H3,(H,34,38)(H,35,39)/t27-,28-/m0/s1
InChI key:InChIKey=KYSDBVSJLBOZDZ-NSOVKSMOSA-N
SMILES:C(N(C[C@@H]([C@H](CC1=CC=CC=C1)NC(OC(C)(C)C)=O)O)NC(OC(C)(C)C)=O)C2=CC=C(C=C2)C3=CC=CC=N3
Synonyms:- 1,1-Dimethylethyl 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylate
- 1-[4-(Pyridin-2-yl)phenyl]-5(S)-2,5-bis [(tert-butyloxycarbonyl)-amino]-4(S)-hydroxyl-6-phenyl-2-azahexane
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl] -2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic Acid 1,1-Dimethylethyl Ester
- 2-[(2S,3S)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazinecarboxylic acid tert-butyl ester
- 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester
- Dimethylethoxy)Carbonyl]Amino]-2-Hydroxy-4-
- Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-
- Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester
- Hydrazinecarboxylic acid, 2-[3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester, [S-(R*,R*)]-
- Hydrazinecarboxylicacid
- Phenylbutyl]-2-[[4-(2-Pyridinyl)Phenyl]Methyl]-,1,1-Dimethylethyl Ester
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Atazanavir Ditertbutyl Analog (tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl)-2-(4-(pyridin-2-yl)benzyl)hydrazine-1-carboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H42N4O5Color and Shape:Off-White SolidMolecular weight:562.31552Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester
CAS:Formula:C32H42N4O5Purity:%Color and Shape:SolidMolecular weight:562.6997Atazanavir EP Impurity J (Atazanavir Di-tert-butyl Analog)
CAS:Formula:C32H42N4O5Color and Shape:White To Off-White SolidMolecular weight:562.71Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl ester
CAS:Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]-, 1,1-dimethylethyl esterPurity:98+%Molecular weight:562.7g/moltert-Butyl N-[(1S,2S)-1-Benzyl-3-[(tert-butoxycarbonylamino)-[[4-(2-pyridyl)phenyl]methyl]amino]-2-hydroxy-propyl]carbamate
CAS:Controlled ProductFormula:C32H42N4O5Color and Shape:NeatMolecular weight:562.70(R,R)-Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir
CAS:Controlled ProductFormula:C32H42N4O5Color and Shape:NeatMolecular weight:562.7Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir
CAS:Controlled Product<p>Applications Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir is an intermediate for the synthesis of Atazanavir (A790051) and the preparation of some peptide analogs.<br>References Martin, J., et al.: Prog. Med. Chem., 32, 239 (1995), Jadhav, P., et al.: J. Med. Chem., 40, 181 (1997), Bold, G., et al.: J. Med. Chem., 41, 3387 (1998);<br></p>Formula:C32H42N4O5Color and Shape:NeatMolecular weight:562.70
![Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbut…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA002BTB.jpg&w=3840&q=75)
![Hydrazinecarboxylic acid, 2-[(2S,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-4-phenylbut…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb%2FOR1043024.jpg&w=3840&q=75)
![tert-Butyl N-[(1S,2S)-1-Benzyl-3-[(tert-butoxycarbonylamino)-[[4-(2-pyridyl)phenyl]methyl]amino]-2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM3514.02.jpg&w=3840&q=75)
